^○Manabu KUBOTA¹, Hitoshi SHIMADA¹, Keisuke TAKAHATA¹, Kenji TAGAI¹, Chie SEKI¹, Yasunori SANO¹, Yasuharu YAMAMOTO¹, Yuhei TAKADO¹, Hitoshi SHINOTOH¹, Hisaomi SUZUKI², Mitsumoto ONAYA², Kazunori KAWAMURA³, Ming-Rong ZHANG³, Makoto HIGUCHI¹ (1. Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 2. Shimofusa Psychiatric Center, Chiba, Japan, 3. Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)

^○Hiroshi NOMURA, Ayame KUBO, Kyoka NISHIMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)

^○Shin HASEGAWA¹, Leo GOTO^{1, 2}, Koji OGOMORI¹, Hiroaki KAWASAKI¹ (1. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Japan, 2. Laboratory of Neuroscience,Department of Psychiatry, Faculty of Medicine, Fukuoka University, Japan)

^○Fan ZENG¹, Junjun NI¹, Wanyi HUANG¹, Muzhou JIANG¹, Zhou WU^{1, 2} (1. Department of Aging Science and Pharmacology, Faculty of Dental Sciences, Kyushu University, 2. OBT Research Center, Faculty of Dental Sciences, Kyushu University)

^○Ichiro KAWAHATA¹, Kyoko HOSHINO², Kazuko HASEGAWA³, Hiroshi ICHINOSE⁴, Kazuto KOBAYASHI⁵, Kohji FUKUNAGA¹ (1. Lab of Pharmacology, Grad Sch of Pharm Sci, Tohoku University, Sendai, Japan, 2. Segawa Memorial Neurological Clinic for Children, Tokyo, Japan, 3. Neurology, Sagamihara National Hospital, Kanagawa, Japan, 4. Grad Sch of Biosci, Tokyo Institute of Technology, Kanagawa, Japan, 5. Dept Mol Gen, Fukushima Medical University, Fukushima, Japan)

^○Yebo GU¹, Junjun NI², Muzhou JIANG², Wanyi HUANG², Zhou WU^{2, 3}, Ichiro TAKAHASHI¹ (1. Section of Orthodontics and Dentofacial Orthopedics, Division of Oral Health, Growth and Development, Faculty of Dental Science, Kyushu University, Fukuoka, Japan, 2. Department of Aging Science and Pharmacology, Faculty of Dental Sciences, Kyushu University, Fukuoka, Japan, 3. OBT Research Center, Faculty of Dental Sciences, Kyushu University, Fukuoka, Japan)

^○Willy Jaya SUENTO^{1, 4}, Kazuo KUNISAWA², Bolati WULAER^{1, 3}, Tsubasa IIDA², Aika KOSUGE², Akihiro MOURI², Kuniaki SAITO^{1, 3}, Toshitaka NABESHIMA³ (1. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 4. Department of Psychiatry, Hasanuddin University Faculty of Medicine, South Sulawesi, Indonesia)

^○Marco Andrea RIVA ¹, Maria Serena PALADINI², Vittoria SPERO², Veronica BEGNI¹, Alice GUIDI², Mariusz PAPP³, Raffaella MOLTENI² (1. Department of pharmacological and biomolecular sciences, University of Milan, 2. Department of Medical Biotechnologies and Translational Medicine, University of Milan, 3. Institute of Pharmacology, Polish Academy of Sciences, Krakow)

^○Yasushi YABUKI, Kohji FUKUNAGA (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University)

^○Akihiro MOURI¹, Yuko MORI², Kazuo KUNISAWA^{1, 3}, Mami HIRAKAWA¹, Tomoaki TESHIGAWARA², Hisayoshi KUBOTA¹, Moe NIIJIMA¹, Hidetsugu FUJIGAKI², Yasuko YAMAMOTO², Toshitaka NABESHIMA³, Kuniaki SAITO² (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan)

^○Yuta Y. AOKI¹, Bun YAMAGATA², Takashi ITAHASHI¹, Junya FUJINO¹, Haruhisa OHTA¹, Osamu TAKASHI¹, Motoaki NAKAMURA¹, Nobumasa KATO¹, Masaru MIMURA², Ryu-ichiro HASHIMOTO¹ (1. Institute of developmental disabilities research, Showa Unviersity, Tokyo, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Daisuke TSUBOI¹, Imrul Hassan MD CHOWDHURY¹, Rei YAMADA², Toshihisa OHTSUKA³, Kozo KAIBUCHI¹ (1. Department of Cell Pharmacology, Nagoya University, 2. Department of Cell Physiology, Nagoya University, 3. Department of Biochemistry, Yamanashi University)

^○Wai Kwong TANG^{1, 2} (1. Department of Psychiatry, the Chinese University of Hong Kong, 2. Shenzhen Research Institute, the Chinese University of Hong Kong)

^○Shintaro OGAWA¹, Kotaro HATTORI^{1, 2}, Daimei SASAYAMA³, Tomoko MIYAKAWA², Megumi TATSUMI^{1, 2}, Sumiko YOSHIDA⁴, Hiroshi KUNUGI¹ (1. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan, 3. Department of Psychiatry, Shinshu University School of Medicine, Nagano, Japan, 4. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○Cenglin XU, Yi WANG, Zhong CHEN (Deparment of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University)

^○Hiroko KOTAJIMA¹, Sakae NARUMI², Kazuhisa SAKAI³, Tsutomu HASHIKAWA⁴, Michisuke YUZAKI⁵, Dai YANAGIHARA⁶ (1. Addictive Substance Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, 2. Department of Physiology, St. Marianna University School of Medicine, 3. Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4. Laboratory for Molecular Mechanisms of Thalamus Development, RIKEN Brain Science Institute, 5. Department of Neurophysiology, Keio University school of medicine, 6. Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo)

^○Hyun Chan Hwang, Kyung Joon MIN, Han Il RYOO, Sol I KIM, Doug Hyun HAN, Sun Mi KIM (Department of Psychiatry, Chung-Ang University Hospital, Seoul, Korea)

^○Tien-Yu CHEN^{1, 4}, Wei-Chung MAO², Nian-Sheng TZENG¹, John WINKELMAN³, Cheryl Ch YANG⁴, Terry Bj KUO⁴, Chi-Shin WU⁵ (1. Department of Psychiatry, Tri-Service General Hospital; School of Medicine, National Defense Medical Center, Taipei, Taiwan, 2. Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan, 3. Department of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA, 4. Institute of brain science, National Yang-Ming University, Taipei, Taiwan, 5. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan)

^○Kotaro HATTA¹, Yasuhiro KISHI², Ken WADA³, Takashi TAKEUCHI⁴, Naoko HASHIMOTO⁵, Kiyoko SUDA⁶, Toshihiro TAIRA⁷, Kazuo TSUCHIDA⁸, Takashi OHMORI⁵, Nobuya AKIZUKI⁶, Yuko NISHIO⁶, Yukiko NAKANISHI⁶, Chie USUI¹, Akiko KURATA⁹, Naoki HORIKAWA¹⁰, Hiroshi EGUCHI¹⁰, Shigeo ITO², Hitoshi MUTO⁴, Hiroyuki NAKAMURA¹¹, Naohisa UCHIMURA¹⁰ (1. Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, Japan, 2. Department of Psychiatry, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan, 3. Department of Psychiatry, Hiroshima City Hospital, Hiroshima, Japan, 4. Department of Psychiatry, Tokyo Medical and Dental University, Tokyo, Japan, 5. Department of Psychiatry, Tokushima Prefectural Central Hospital, Tokushima, Japan, 6. Department of Psychooncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan, 7. Department of Psychiatry, Fukuyama City Hospital, Fukuyama, Japan, 8. Department of Psychiatry, Kurashiki Central Hospital, Kurashiki, Japan, 9. Department of Psychiatry and Neurosciences, Hiroshima University Hospital, Hiroshima, Japan, 10. Department of Psychiatry, Kurume University School of Medicine, Kurume, Japan, 11. Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan)

^○Akihiro YAMANAKA^{1, 2} (1. Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University , 2. CREST, JST, Japan)

^○Chun-Yen CHEN^{1, 2}, Yi-Wei YEH^{1, 2}, Shin-Chang KUO^{1, 2}, San-Yuan HUANG^{1, 2} (1. Department of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan. , 2. National Defense Medical Center, Taipei, Taiwan)

^○Ekachaeryanti ZAIN, Sonny Teddy LISAL, Saidah SYAMSUDDIN, Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia)

^○Cheolmin SHIN, Changsu HAN, Seung-Hoon LEE (Korea University Ansan Hospital)

^○Hitoshi SAKURAI^{1, 2}, David MISCHOULON¹, Maurizio FAVA¹, Cristina CUSIN¹ (1. Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, USA, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Hitoshi SAKURAI^{1, 2}, Cristina CUSIN¹, Kate BENTLEY¹, Paola PEDRELLI¹, Simmie FOSTER¹, Maurizio FAVA¹, David MISCHOULON¹ (1. Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Jeongwan HONG (Iksan Hospital)

^○Saeheon JANG (Department of psychiatry, Bongseng Memorial Hospital)

^○Natalia Dewi WARDANI¹, Alifiati FITRIKASARI¹, Hang Gunawan ASIKIN¹, Tanjung Ayu SUMEKAR¹, Fanti SAKTINI¹, Moh SULCHAN² (1. Psychiatry Departemen, Medical Faculty Diponegoro University Semarang, 2. Clinical Nutrition Study Program, Medical Faculty Diponegoro University)

^○Alifiati FITRIKASARI, Natalia Dewi WARDANI, Nurulita TUNJUNG SARI (Psychiatry Departemen Medical Faculty Diponegoro University)

^○Jane Pei-Chen CHANG^{1, 2, 3}, Kuan-Pin SU^{1, 2, 3}, Valeria MONDELLI¹, Carmine M. PARIANTE¹ (1. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 2. Department of Psychiatry and Mind-Body Interface (MBI) Lab, China Medical University Hospital, Taichung, Taiwan, 3. College of Medicine, China Medical University, Taichung, Taiwan)

^○Yanhui LIAO (Mental Health Institute, The Second Xiangya Hospital, Central South University)

^○Chih-Ken CHEN¹, Ming-Chyi HUANG², Yu-Chao HSU³, Shih-Ku LIN² (1. Department of Psychiatry, Chang Gung Memorial Hospital, Keelung, Chang Gung University School of Medicine, Taiwan, 2. Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 3. Department of Urology, Chang Gung Memorial Hospital, Linko, Taiwan)

^○San-Yuan HUANG¹, Chang-Chih TSOU², Chih-Yun HUANG³ (1. Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, 2. Doctoral Degree Program in Translational Medicine, National Defense Medical Center and Academia Sinica, Taipei, Taiwan, R.O.C., 3. School of Public Health, National Defense Medical Center, Taipei, Republic of China)

^○Chun-Long LIN^{1, 3}, San-Yuan HUANG^{1, 2} (1. Graduate Institute of Medical Sciences,National Defense Medical Center, 2. Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C., 3. Department of Psychiatry, Military Taoyuan General Hospital, Taoyuan, Taiwan, R.O.C.)

^○Dmitriy PANOV^{1, 2}, Valery GAFAROV^{1, 2}, Elena GROMOVA^{1, 2}, Vladimir MAXIMOV¹, Igor GAGULIN^{1, 2}, Almira GAFAROVA^{1, 2} (1. Institute of Internal and Preventive Medicine - branch of Institute of Cytology and Genetics SB RAS, 2. Collaborative laboratory epidemiology cardiovascular diseases )

^○Shin-Chang KUO^{1, 2}, Yi-Wei YEH^{1, 2}, Chun-Yen CHEN^{1, 2}, Chang-Chih HUANG^{1, 3}, Chun-Long LIN^{1, 4}, San-Yuan HUANG^{1, 2} (1. Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C, 2. Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C., 3. Department of Psychiatry, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan, R.O.C, 4. Department of Psychiatry, Hsinchu Branch, Taoyuan Armed Forces General Hospital, Hsinchu, Taiwan, R.O.C.)

^○Hitomi SASAMORI, Yu OHMURA, Mitsuhiro YOSHIOKA (Department of Neuropharmacology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan)

^○Masahiro OHGIDANI, Takahiro A. KATO (Department of Neuropsychiatry, Kyushu University)

^○Masaki TANAKA¹, Takahira SHIRAHASE¹, Yoshihisa WATANABE² (1. Department of Anatomy and Neurobiology, 2. Basic Geriatrics)

^○Shunya KUROKAWA¹, Taishiro KISHIMOTO^{1, 2}, Kuan-pin SU³, Jane Pei-Chen CHANG³, Hui-Chih CHANG³, Xin YU⁴, Nuno RODRIGUES-SILVA⁵, Jimmi NIELSEN⁶, Anish UNADKAT⁷, David CASTLE⁷, Peter M. HADDAD⁸, Deyvis ROCHA⁹, Ary GADELHA⁹, Styliani KALIORA², Georgios PETERIDES², Ofer AGID¹⁰, Yuki TAZAWA¹, Akihiro TAKAMIYA¹, Toshiro HORIGOME¹, John KANE² (1. Department of Psychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, The Zucker Hillside Hospital, New York, 3. Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan, 4. Peking University Institute of Mental Health (Sixth Hospital), Beijing, 5. Department of Psychiatry and Mental Health, Cova da Beira University Healthcare Center, Covilhã, Portugal, 6. Mental health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark, 7. The University of Melbourne and St Vincent’s Hospital Melbourne, Australia, 8. Department of Psychiatry, University of Manchester, Manchester, UK, 9. Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil, 10. Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Canada)

^○Manabu KUBOTA^{1, 2}, Sho MORIGUCHI^{1, 3}, Keisuke TAKAHATA^{1, 4}, Shinichiro NAKAJIMA^{3, 4}, Nobuyuki HORITA⁵ (1. Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 2. Department of Psychiatry, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada, 4. Department of Neuropsychiatry, Keio University Graduate School of Medicine, Tokyo, Japan, 5. Yokohama City University Graduate School of Medicine, Yokohama, Japan)

^○David D. KIM^{1, 2}, Alasdair M. BARR^{1, 2}, Cynthia LU², S. Evelyn STEWART^{2, 3}, William G. HONER^{2, 3}, Ric M. PROCYSHYN^{2, 3} (1. Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada, 2. British Columbia Mental Health & Substance Use Services, Vancouver, Canada, 3. Department of Psychiatry, University of British Columbia, Vancouver, Canada)

^○Nageiswari PARATHY, David GROENEWOUD, Hui Min MAK, Peiyan WONG, Gavin DAWE (National University of Singapore)

^○Shinobu HIRAI¹, Hideki MIWA², Tomoko TANAKA¹, Yasuto KUNII^{4, 5}, Makoto ARAI³, Haruo OKADO¹ (1. Lab. of Neural Development, Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Molecular Neuropsychopharmacology Section, Department of Neuropsychopharmacology, National Institute of Mental Health: National Center of Neurology and Psychiatry, Tokyo, Japan, 3. Lab. of Schizophrenia Research, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 4. Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan, 5. Department of Psychiatry, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan)

^○Jay P. NAKAMURA¹, Anna SCHROEDER¹, Andrew GIBBONS¹, Xin DU¹, Maarten VAN DEN BUUSE³, Suresh SUNDRAM^{1, 2}, Rachel Anne HILL¹ (1. Department of Psychiatry, Monash University, Clayton, Victoria, Australia, 2. Monash Medical Centre, Monash Health, Clayton, Victoria, Australia, 3. School of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia)

^○Brian DEAN^{1, 2, 4}, Andrew GIBBONS¹, Madhara UDAWELA^{1, 2}, Elizabeth SCARR^{1, 2, 3} (1. Molecular Psychiatry Laboratory, Florey Institute for Neuroscience and Mental Health, Victoria, Australia., 2. CRC for Mental Health, Victoria, Australia., 3. Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Victoria, Australia., 4. Centre for Mental Health, the Faculty of Health, Arts and Design, Swinburne University, Victoria, Australia.)

^○Keiko IKEMOTO (Dep. Psychiatry, Iwaki City Medical Center)